The Methodological Quality of TCM Clinical Practice Guidelines for Coronary Heart Disease was Evaluated Based on Multiple Tools
- VernacularTitle:基于多种工具评价冠心病中医临床实践指南的方法学质量
- Author:
Yudong YU
1
;
Jingjing YAN
;
Bin LI
;
Jia LI
;
Pengzhen YU
;
Beibei LIANG
;
Lanfang ZHONG
Author Information
- Publication Type:Journal Article
- Keywords: Coronary heart disease; Guideline evaluation; AGREE Ⅱ; AGREE-China; STAR
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2025;27(1):110-120
- CountryChina
- Language:Chinese
- Abstract: Objective Based on the three tools of the AGREE Next Steps Consortium(AGREE Ⅱ),China Clinical Guidelines Evaluation System(AGREE-China)and Scientificity Transparency Applicability Rankings(STAR),the methodological quality of Chinese medicine clinical treatment guidelines for coronary heart disease published by domestic institutions was systematically evaluated.Methods Computer system retrieval of China National Knowledge Infrastructure(CNKI),WanFang Data,Chinese Science and Technology Journal Database(VIP),China Biology Medicine(CBM)and Yimai Tong,and collect clinical practice guidelines of traditional Chinese medicine for coronary heart disease issued by domestic institutions(including expert consensus).The search period was from the establishment of the database to December 31,2023.Results A total of 21 guidelines were included.AGREE Ⅱ recommended 13 for grade A and 8 for grade B.The approval-China review strongly recommends 12,weakly recommends 8,and does not recommend 1.The highest STAR rating is a 4.0 star recommendation and the lowest is a 1.5 star recommendation.Conclusions There are a large number of TCM diagnosis and treatment guidelines and expert consensus on coronary heart disease in China,but the quality is uneven.It is suggested that the future guideline formulation should pay attention to the evidence-based principle,promote the standardization and standardization of the guideline formulation,and improve the scientific and applicability of the guideline.
